Ajanta Pharma Limited (NSE: AJANTPHARM)

Ajanta Pharma Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Revenue	44,908	42,087	37,426	33,410	28,897	25,879
Revenue Growth (YoY)	15.06%	12.45%	12.02%	15.62%	11.66%	25.91%
Cost of Revenue	11,426	11,210	11,102	8,840	6,832	6,896
Gross Profit	33,482	30,877	26,324	24,570	22,065	18,982
Selling, General & Admin	10,215	9,122	7,978	6,571	5,523	4,890
Other Operating Expenses	10,599	9,944	10,241	8,667	6,478	7,258
Operating Expenses	22,183	20,420	19,527	16,491	13,162	13,105
Operating Income	11,300	10,457	6,798	8,079	8,903	5,877
Interest Expense	-107.7	-72.1	-58.4	-102	-82.7	-119.1
Interest & Investment Income	277.1	277.1	84.6	146.5	35.1	44.1
Currency Exchange Gain (Loss)	-118.9	158.7	660.7	563.7	45.1	745.3
Other Non Operating Income (Expenses)	407.8	264.1	61.5	323.8	40.9	68.7
EBT Excluding Unusual Items	11,758	11,084	7,546	9,011	8,941	6,616
Gain (Loss) on Sale of Investments	20.1	20.1	-40	122.8	82.7	63.8
Gain (Loss) on Sale of Assets	34.9	34.9	-53.5	-38.7	-22.1	-1
Other Unusual Items	-	-	-	-	-	-39.2
Pretax Income	11,813	11,139	7,453	9,095	9,002	6,640
Income Tax Expense	3,063	2,978	1,573	1,968	2,463	1,963
Net Income	8,750	8,162	5,880	7,127	6,539	4,677
Net Income to Common	8,750	8,162	5,880	7,127	6,539	4,677
Net Income Growth	32.54%	38.81%	-17.50%	8.99%	39.81%	20.86%
Shares Outstanding (Basic)	126	126	128	130	131	131
Shares Outstanding (Diluted)	126	126	128	130	131	131
Shares Change (YoY)	-1.05%	-1.65%	-1.19%	-0.74%	-0.21%	-0.85%
EPS (Basic)	69.65	64.82	45.89	54.97	50.06	35.73
EPS (Diluted)	69.60	64.77	45.89	54.96	50.06	35.73
EPS Growth	33.95%	41.14%	-16.50%	9.79%	40.10%	21.93%
Free Cash Flow	9,127	6,327	6,176	4,129	4,047	2,174
Free Cash Flow Per Share	72.60	50.21	48.21	31.84	30.98	16.60
Dividend Per Share	54.000	36.000	7.000	6.333	6.333	8.667
Dividend Growth	440.00%	414.29%	10.53%	0%	-26.92%	44.45%
Gross Margin	74.56%	73.36%	70.34%	73.54%	76.36%	73.35%
Operating Margin	25.16%	24.84%	18.16%	24.18%	30.81%	22.71%
Profit Margin	19.48%	19.39%	15.71%	21.33%	22.63%	18.07%
Free Cash Flow Margin	20.32%	15.03%	16.50%	12.36%	14.00%	8.40%
EBITDA	12,496	11,638	7,952	9,173	9,889	6,673
EBITDA Margin	27.83%	27.65%	21.25%	27.45%	34.22%	25.78%
D&A For EBITDA	1,196	1,181	1,154	1,094	985.9	795.5
EBIT	11,300	10,457	6,798	8,079	8,903	5,877
EBIT Margin	25.16%	24.84%	18.16%	24.18%	30.81%	22.71%
Effective Tax Rate	25.93%	26.73%	21.10%	21.64%	27.36%	29.56%
Revenue as Reported	45,783	42,933	38,413	34,567	29,157	26,801
Advertising Expenses	-	44.9	50.2	47.8	16.2	14

Source: S&P Capital IQ. Standard template. Financial Sources.